CDCA2 expression was not associated with clinical factors including disease stage and international prognostic index (IPI) (Supplementary Figure S1A–D); however, GCB-DLBCL patients displayed increased CDCA2 expression in comparison to ABC and unclassified patients (p ≤ 0.05) (Figure 1B). This evidence concerns the gene CDCA2 and diffuse large B-cell lymphoma.